Rifaximin is the generic ingredient in one branded drug marketed by Salix Pharms and is included in one NDA. There are twenty-nine patents protecting this compound.
Drug patent litigation for RIFAXIMIN.
This ingredient has one hundred and eigthy-two patent family members in thirty-nine countries.
Three suppliers are listed for this compound. There are two tentative approvals for this compound.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
